Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT.
Fiche publication
Date publication
juillet 2022
Journal
Cancer medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse
Tous les auteurs :
Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M
Lien Pubmed
Résumé
Achieving complete remission (CR) is the main goal in AML treatment and a prerequisite for successful autologous stem cell transplantation (ACT).
Mots clés
acute myeloid leukemia, autologous, complete remission, induction chemotherapy, stem cell transplantation
Référence
Cancer Med. 2022 07 26;: